INTRODUCTION
O cular surface squamous neoplasia (OSSN) is the most common nonpigmented tumor of the ocular surface [1] . It comprises a range of dysplasia including corneal-conjunctival intraepithelial neoplasia (CIN) and invasive squamous cell carcinoma (SCC) [2] . Amniotic membrane transplantation (AMT) is an effective method for ocular surface reconstruction after wide excision of OSSN [3] . Several topical therapies have also been proved effective in OSSN treatment, including mitomycin C [4] , 5-fluorouracil [5] , and interferon alfa-2b (IFNα2b) [6] [7] . In particular, topical IFNα2b has gained appeal for OSSN treatment because of its minimal toxicity [8] . However, the mean tumor resolution time was as long as 12wk by topical IFNα2b treatment for CIN [6] . Furthermore, it was suggested that topical IFNα2b alone not be used in eyes with SCC [6] . To reduce the risk of recurrence after surgery [9] , we chose topical IFNα2b as an adjuvant therapy in our clinical practice. No study has specifically evaluated the outcome of AMT with topical IFNα2b after excision of OSSN. Herein, we retrospectively reviewed our clinical experiences of successfully treating 12 eyes of 12 patients with OSSN.
SUBJECTS AND METHODS
This study was approved by the Ethics Committee of Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology according to the tenets of the Declaration of Helsinki. Twelve patients (12 eyes) with a clinical diagnosis of OSSN undergone AMT with topical IFNα2b after meticulous excision during November 2012 and May 2016 were included. Clinical data concerning age, sex, best corrected visual acuity (BCVA), tumor location, epithelial healing, complications, pathological diagnosis and recurrence were reviewed and analyzed. Human amniotic membrane (AM) were prepared using previously described method [10] . Topical IFNα2b (1 MIU/mL) was compounded by adding 4 mL of distilled sterile water to 1 mL of 5 MIU/mL IFNα2b (Anfulong, Tianjing Sinobioway Biomedicine, China) and preserved in refrigerator at 4℃. After topical and peribulbar anesthesia, all tumors were resected intact, using the 'no touch' technique with at least 2-mm normal-looking conjunctiva [11] . All surgically resected specimens were sent for pathology diagnosis. A superficial keratectomy or sclerectomy was performed if there was corneal or scleral infiltration. The defects of both conjunctiva and cornea were covered by one sheet of cryopreserved AM with epithelial side facing up, which was then interrupted secured to conjunctiva and episclera with 8/0 vicryl sutures (Ethicon, US) or 10/0 nylon sutures (Alcon, Fort Worth, TX, USA). Topical IFNα2b and antibiotic eye drops were used 4 times daily for 4 and 2wk respectively. The 10/0 nylon sutures were removed 2wk after surgery. All patients were followed up daily for 1wk, weekly for 1mo and then at different intervals after surgery.
RESULTS AND DISCUSSION
Relevant clinical data are summarized in Table 1 . There were 12 patients (83.3% males) with a mean age of 66±10 (51 to 79)y. The average follow-up was 23±10 (6 to 40)mo. Complaints A 79-year-old man had complained of foreign body sensation and redness in his left eye for 22mo. Slit lamp examination showed an 8-hour elevated lesion with leukoplakia and corkscrewed feeder vessels on the superior ocular surface, and gelatinous appearance on the temporal and inferior cornea ( Figure 1A ). The tumor involved conjunctiva, lamellar cornea and sclera were removed ( Figure 1B) . AM was applied to cover the entire denuded scleral and corneal surface ( Figure 1C) . A diagnosis of SCC was made after surgery. The ocular surface was stable without recurrence and inflammation at 12mo follow-up ( Figure 1D ). Case 7: A 73-year-old man had a diffused red mass in his left eye for 26mo. Slit lamp showed a large elevated papiliform tumor with feeder vessels in the nasal half of the ocular surface ( Figure 1E ) and another small lesion in the temporal limbus ( Figure 1E , white arrow). The patient underwent absolute tumor excision and AMT ( Figure  1F) . A transparent cornea ( Figure 1G ) and a stable ocular surface ( Figure 1H ) were perfectly reconstructed without any inflammation or recurrence for 23mo of follow-up. The BCVA improved to 20/30 from 20/200. Case 10: A 51-year-old man presented with a gelatinous tumor involving the 12h limbus ( Figure 1I , between white and black dotted line). AMT was performed to cover the entire denuded ocular surface after the tumor were removed ( Figure 1J ). Neovascularization were noted in the periphery cornea at 2wk after surgery ( Figure 1K , white arrows), which regressed automatically within 1mo. A transparent cornea and stable ocular surface were maintained for 14mo follow-up ( Figure 1L ).
AMT is widely applied in reconstruction of ocular surface following generous excision of ocular surface tumors [3] . In this study, topical steroids were not used due to their association with the occurrence of OSSN [12] . All ocular surfaces were stable without any inflammation at the last follow-up. The AM exerted the effect of suppressing inflammation and angiogenesis [13] . Although limbal involvement was present in all 12 eyes and 12-hour limbal excision was performed in 2 patients (Cases 7 and 10), limbal stem cell deficiency was not observed. The AM probably promoted self-renewal of stem cells by creating a noninflamed limbal niche [14] . We also attribute the absent of recurrence to topical IFNα2b drops. IFNα2b was advocated as sole therapy of OSSN [6] [7] with minimal side effect [8] , however, it requires a longer treatment [6] and should not be used alone in eyes with SCC [6] . Adjuvant interferon therapy were suggested in patients with tarsal involvement and recurrent disease [15] . Our preferred method is to prescribe topical IFNα2b (1 MIU/mL) 4 times daily for 1mo after surgery. As a conclusion, AMT with topical IFNα2b after tumor excision restores a healthy ocular surface in OSSN without complication and recurrence. These finding provides an efficient treatment for OSSN. 
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